Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L V Wilton

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Toxicology|August 1, 1976
Inhalation toxicity studies on cigarette smoke II. Tobacco smoke inhalation dosimetry studies on small laboratory animalsR Binns, J L Beven, L V Wilton, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Is the incidence of upper respiratory tract infection independent of drug treatment in large cohort studies of longer term use drugs?L V Wilton, S N Freemantle, R Martin, et al.
Toxicology|August 1, 1976
Inhalation toxicity studies on cigarette smoke III. Tobacco smoke inhalation dosimetry study on ratsR Binns, J L Beven, L V Wilton, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Safety profile of nicorandil--prescription-event monitoring (PEM) studyN Dunn, S Freemantle, G Pearce, et al.
BMJ (Clinical Research Ed.)|March 17, 2001
Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in EnglandS A Shakir, L V Wilton, A Boshier, et al.
BMJ (Clinical Research Ed.)|July 10, 1998
Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational studyR M Martin, K V Kapoor, L V Wilton, et al.
Lancet (London, England)|December 14, 2001
Prescription-event monitoring and reporting of adverse drug reactionsE Heeley, J Riley, D Layton, et al.
Journal of Psychopharmacology (Oxford, England)|July 13, 2001
Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapineL V Wilton, E L Heeley, R M Pickering, et al.
Journal of Psychopharmacology (Oxford, England)|January 5, 2002
The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in EnglandP N Biswasl, L V Wilton, G L Pearcel, et al.
European Journal of Clinical Pharmacology|January 1, 1997
A comparison of two cohort studies evaluating the safety of cisapride: Prescription-Event Monitoring and a large phase IV studyE Wager, P J Tooley, G L Pearce, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Toxicology|August 1, 1976
Inhalation toxicity studies on cigarette smoke II. Tobacco smoke inhalation dosimetry studies on small laboratory animalsR Binns, J L Beven, L V Wilton, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Is the incidence of upper respiratory tract infection independent of drug treatment in large cohort studies of longer term use drugs?L V Wilton, S N Freemantle, R Martin, et al.
Toxicology|August 1, 1976
Inhalation toxicity studies on cigarette smoke III. Tobacco smoke inhalation dosimetry study on ratsR Binns, J L Beven, L V Wilton, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Safety profile of nicorandil--prescription-event monitoring (PEM) studyN Dunn, S Freemantle, G Pearce, et al.
BMJ (Clinical Research Ed.)|March 17, 2001
Cardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in EnglandS A Shakir, L V Wilton, A Boshier, et al.
BMJ (Clinical Research Ed.)|July 10, 1998
Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational studyR M Martin, K V Kapoor, L V Wilton, et al.
Lancet (London, England)|December 14, 2001
Prescription-event monitoring and reporting of adverse drug reactionsE Heeley, J Riley, D Layton, et al.
Journal of Psychopharmacology (Oxford, England)|July 13, 2001
Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapineL V Wilton, E L Heeley, R M Pickering, et al.
Journal of Psychopharmacology (Oxford, England)|January 5, 2002
The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in EnglandP N Biswasl, L V Wilton, G L Pearcel, et al.
European Journal of Clinical Pharmacology|January 1, 1997
A comparison of two cohort studies evaluating the safety of cisapride: Prescription-Event Monitoring and a large phase IV studyE Wager, P J Tooley, G L Pearce, et al.
Pageof 4